Harry M Lever MD
Echocardiography, Non-Invasive Cardiology
Medical Director of the Hypertrophic Cardiomyopathy Clinic at Cleveland clinic
Join to View Full Profile
9500 Euclid AveCleveland, OH 44195
Phone+1 800-223-2273
Fax+1 216-986-1191
Dr. Lever is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Rochester Medical CenterFellowship, Cardiovascular Disease, 1973 - 1976
UPMC Medical EducationResidency, Internal Medicine, 1971 - 1974
University of Pittsburgh School of MedicineClass of 1971
Certifications & Licensure
OH State Medical License 1978 - 2026
PA State Medical License 1972 - 2026
CA State Medical License 2010 - 2020
MI State Medical License 2004 - 2020
NY State Medical License 1977 - 2006
IL State Medical License 2004 - 2005
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2011, 2013-2014, 2016-2017
Clinical Trials
- Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM Start of enrollment: 2014 Mar 01
Publications & Presentations
PubMed
- 15 citationsCardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial.Christoffer Rasmus Vissing, Anna Axelsson Raja, Sharlene M Day, Mark W Russell, Kenneth Zahka
JAMA Cardiology. 2023-11-01 - Transforming Growth Factor-β Analysis of the VANISH Trial Cohort.Yuri Kim, Mitra Mastali, Jennifer E Van Eyk, E John Orav, Christoffer R Vissing
Circulation. Heart Failure. 2023-04-01 - 52 citationsVentricular Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy (Analysis Spanning 60 Years Of Practice): AJC Expert Panel.Barry J Maron, Joseph A Dearani, Nicholas G Smedira, Hartzell V Schaff, Shuiyun Wang
The American Journal of Cardiology. 2022-10-01
Journal Articles
- Prognostic Value of Global Longitudinal Strain in Hypertrophic CardiomyopathyMilind Y Desai, Zoran B Popovic, Harry M Lever, Divyanshu Mohananey, ScienceDirect
- Original Investigation Late Gadolinium Enhancement in Patients with Hypertrophic Cardiomyopathy and Preserved Systolic FunctionScott D Flamm, Oussama Wazni, Harry M Lever, Maran Thamilarasan, Milind Y Desai, Nicholas G Smedira, Zoran B Popovic, ScienceDirect
Press Mentions
The FDA Often Doesn’t Test Generic Drugs for Quality Concerns, so ProPublica DidDecember 22nd, 2025- INVESTIGATING GENERICS: America’s Overlooked Drug CrisisJune 19th, 2025
These Pills Could Kill YouMay 24th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
